A. Mark Fendrick, MD

Articles by A. Mark Fendrick, MD

Cardiovascular Risk Reduction in the Workforce: Optimizing Cholesterol Management to Reduce the Burden of Cardiovascular Disease

ByF. Randy Vogenberg, RPh, PhD,A. Mark Fendrick, MD

August 20th 2010

Investment in prevention and treatment of cardiovascular disease must consider overall effect on employee health and productivity, not exclusively direct health coverage costs.

Latest Updated Articles

Cardiovascular Risk Reduction in the Workforce: Optimizing Cholesterol Management to Reduce the Burden of Cardiovascular Disease
August 20th 2010

A. Mark Fendrick, MD

Articles by A. Mark Fendrick, MD

Cardiovascular Risk Reduction in the Workforce: Optimizing Cholesterol Management to Reduce the Burden of Cardiovascular Disease

Latest Updated Articles

Trending on Pharmacy Times

What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results

First-in-Human In Vivo CAR-T Therapy Shows Encouraging Activity in Relapsed/Refractory Multiple Myeloma

FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19 in Adolescents and Adults

Darovasertib Plus Crizotinib Shows Striking Efficacy in HLA-A2–Negative Metastatic Uveal Melanoma, OptimUM-02 Results Show

Apnimed Submits NDA for AD109 Following Positive Phase 3 Results in Obstructive Sleep Apnea